Treatment of Nicotine Use in Adolescents Under 18 Years of Age: An Official American Thoracic Society Clinical Practice Guideline
Authors:
- Sarah E. BauerSBSarah E. Bauer
- Madalina MacreaMMMadalina Macrea
- Alicia CaseyACAlicia Casey
- Elif DagliEDElif Dagli
- Michelle N. EakinMEMichelle N. Eakin
- Harold J. FarberHFHarold J. Farber
- Priscilla GonzalezPGPriscilla Gonzalez
- Don HayesDHDon Hayes
- Shih-Wen HuSHShih-Wen Hu
- Hasmeena KathuriaHKHasmeena Kathuria
- Shandra L. KnightSKShandra L. Knight
- Theo J. MoraesTMTheo J. Moraes
Open Access
- 1 September 2025
- journal article
- practice guideline
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (9) , 1584-1599
Abstract
Background: The rising popularity of electronic cigarettes (e-cigarettes), the nicotine product that is most used by adolescents since 2014, has reversed decades of progress in declining youth tobacco use. E-cigarette use in adolescents is associated with future smoking, and evidence is mounting of an increased association with nicotine dependence. Therapies used to treat nicotine dependence in adults include pharmacotherapy and behavioral interventions. Pediatric guidelines recommend routine screening for any tobacco product use beginning at age 10 years. The goal of this guideline was to develop an evidence-based clinical practice guideline for the treatment of nicotine use in adolescents. Methods: We summarized evidence addressing five PICO (patients, intervention, comparator, and outcome) questions, which were formulated by a multidisciplinary panel of experts and methodologists using the evidence-to-decision framework. The Grading of Recommendations, Assessment, Development, and Evaluation (or, GRADE) approach was used to evaluate the certainty in evidence and generate actionable recommendations, which were voted on by the panel. Results: The panel members considered the strength of the evidence as well as the potential benefits of the treatment modality from a clinical standpoint. The overall quality of the evidence was weak. Recommendations for or against the treatment modality for nicotine use were developed. Conclusions: This expert panel provides evidence-based recommendations for treating nicotine use in adolescents 10 to 18 years of age.Keywords
This publication has 77 references indexed in Scilit:
- Varenicline for Youth Nicotine Vaping CessationJAMA, 2025
- A Vaping Cessation Text Message Program for Adolescent E-Cigarette UsersJAMA, 2024
- Longitudinal Assessments of Neurocognitive Performance and Brain Structure Associated With Initiation of Tobacco Use in Children, 2016 to 2021JAMA Network Open, 2022
- Evaluation of Self-reported Cannabis Vaping Among US Youth and Young Adults Who Use e-CigarettesJAMA Pediatrics, 2022
- Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant PersonsJAMA, 2021
- Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and AdolescentsJAMA, 2020
- Efficacy and Safety of Varenicline for Adolescent Smoking CessationJAMA Pediatrics, 2019
- The effects of nicotine on human fetal developmentBirth Defects Research Part C: Embryo Today: Reviews, 2016
- Randomized, Double-blind, Placebo-Controlled Trial of 2 Dosages of Sustained-Release Bupropion for Adolescent Smoking CessationArchives of Pediatrics & Adolescent Medicine, 2007
- Brief Interventions and Motivational Interviewing With Children, Adolescents, and Their Parents in Pediatric Health Care SettingsArchives of Pediatrics & Adolescent Medicine, 2005